Jiuwei Ping Capsule on cardiac function in patients with chronic heart failure high-sensitivity C-reactive protein and blood lipids.docVIP

 PAGE \* MERGEFORMAT 16 Jiuwei Ping Capsule on cardiac function in patients with chronic heart failure high-sensitivity C-reactive protein and blood lipids [Abstract] Objective To study the taste level nine capsules in chronic heart failure (CHF) in patients with cardiac function, serum high-sensitivity C-reactive protein (hs-CRP) and blood lipids. Methods 78 patients were randomly divided into 2 groups, control group ( 38) angiotensin converting enzyme inhibitors, angiotensin receptor blockers, β adrenergic receptor blockers, diuretics and digitalis preparations treatment group (40 cases) in the control group based on the use Ping Jiuwei capsules for 6 months after treatment by echocardiography, and enhance the immune turbidimetry and heart function were measured by hs-CRP levels. Results After treatment, group 2 NYHA functional class, left ventricular end diastolic diameter and left ventricular systolic diameter were significantly decreased in the end (P lt;0.05), and the treatment group was significantly lower than the control group (P lt;0.05), left ventricular ejection fraction and mitral flow peak velocity of early ventricular filling / atrial contraction ventricular filling late blood the ratio of peak flow velocity increased significantly (P lt;0.05), and the treatment group was significantly higher (P lt;0.05). the treatment group, hs-CRP were significantly lower than that before treatment (P lt;0,05), and significantly lower in the control group (P lt;0.05), the control group before and after treatment showed no statistical significance. Conclusion capsules Jiuwei level while improving heart function can reduce serum hs-CRP levels. [Keywords:] nine capsules taste level, chronic heart failure, heart function, high-sensitivity C-reactive protein Abstract: Objective To evaluate the effect of Jiuwei Pingzhi Jiaonang on cardiac function, high-sensitivity C-reactive protein (hs-CRP) and blood lipids in patients with chronic cardiac failure (CHF). M